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Background: The angiotensin system has several non-vascular functions in the central nervous system. For instance,
inhibition of the brain angiotensin system results in a reduction in neuronal death following acute brain injury such
as ischemia and intracerebral hemorrhage, even under conditions of constant blood pressure. Since endogenous
zinc has been implicated as a key mediator of ischemic neuronal death, we investigated the possibility that the
angiotensin system affects the outcome of zinc-triggered neuronal death in cortical cell cultures.
Results: Exposure of cortical cultures containing neurons and astrocytes to 300 μM zinc for 15 min induced
submaximal death in both types of cells. Interestingly, addition of angiotensin II significantly enhanced the
zinc-triggered neuronal death, while leaving astrocytic cell death relatively unchanged. Both type 1 and 2
angiotensin II receptors (AT1R and AT2R, respectively) were expressed in neurons as well as astrocytes. Zinc
neurotoxicity was substantially attenuated by PD123319, a specific inhibitor of AT2R, and augmented by CGP42112,
a selective activator of AT2R, indicating a critical role for this receptor subtype in the augmentation of neuronal cell
death.
Because zinc toxicity occurs largely through oxidative stress, the levels of superoxides in zinc-treated neurons were
assessed by DCF fluorescence microscopy. Combined treatment with zinc and angiotensin II substantially increased
the levels of superoxides in neurons compared to those induced by zinc alone. This increase in oxidative stress by
angiotensin II was completely blocked by the addition of PD123319. Finally, since zinc-induced oxidative stress may
be caused by induction and/or activation of NADPH oxidase, the activation status of Rac and the level of the
NADPH oxidase subunit p67phox were measured. Angiotensin II markedly increased Rac activity and the levels of
p67phox in zinc-treated neurons and astrocytes in a PD123319-dependent manner.
Conclusion: The present study shows that the angiotensin system, especially that involving AT2R, may have an
oxidative injury-potentiating effect via augmentation of the activity of NADPH oxidase. Hence, blockade of
angiotensin signaling cascades in the brain may prove useful in protecting against the oxidative neuronal death
that is likely to occur in acute brain injury.
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Mechanisms of neuronal death associated with acute
brain injuries such as ischemia and trauma have been
extensively investigated over recent decades [1-3]. Ini-
tially, calcium overload induced by glutamate was con-
sidered a common mechanism for neuronal death in a
wide variety of neurological conditions [4]. However,
attempts to develop anti-excitotoxic agents as neuro-
protectants, especially in ischemic stroke, have been
unsuccessful, dampening the initial enthusiasm for this
unifying mechanism [5]. Instead, recent evidence indi-
cates that multiple mechanisms, including glutamate
toxicity, oxidative stress and apoptosis, may act in concert
to cause neuronal death in acute brain injury. For instance,
glutamate neurotoxicity induces calcium overload [6],
which then activates oxidative stress [7]. Reperfusion
injury also enhances the production of reactive oxygen
species (ROS) [8,9]. In both cases, the resulting increase in
oxidative stress causes further glutamate release [10] and
excitotoxicity. In addition, calcium-induced apoptosis,
inflammation, and autophagy contribute to neuronal
death under certain circumstances [3,11].
Endogenous zinc may be another key player in neuronal
death following acute brain injury [12]. Like other tissues,
the brain contains high levels of intracellular zinc [13]. Be-
cause most zinc ions are tightly bound to macromolecules
such as nucleic acids and proteins, the level of free zinc in
the cytosol is very low, probably in the low nanomolar
range [14,15]. The brain, however, has a special pool of
zinc in a subset of synaptic vesicles. Glutamatergic synap-
tic boutons in the forebrain, especially those in the cortical
association systems, contain a large amount of free or
loosely bound zinc [14]. Although the function of synaptic
zinc is still under intensive investigation, a growing body
of evidence suggests that similar to glutamate, zinc is re-
leased with neuronal activity or membrane depolarization
[16-18]. As is the case for glutamate, if a sufficiently high
amount of zinc is released during acute brain injury, it can
induce neuronal death by entering neurons via calcium-
permeable routes [19]. Alternatively, oxidative stress may
induce intracellular zinc release from organelles and
zinc-binding proteins such as metallothioneins [20,21],
again contributing to cell death. Supporting the role of
zinc in acute brain injury, several studies have shown
that 1) zinc accumulates in degenerating neuronal cells,
and 2) blockade of zinc accumulation with chelators
substantially reduces neuronal death in diverse models
of acute brain injury [22].
Angiotensin II has long been known as a potent vaso-
constrictor [23,24]. It is produced from its precursor
angiotensinogen by activated angiotensin converting en-
zyme (ACE) [25]. In addition to its vasoconstrictive effect,
angiotensin II induces aldosterone release, sodium and
water retention, and increased fluid intake, all of whichcontribute to blood pressure and fluid homeostasis [26].
Initially, the role of angiotensin II in the brain was not ap-
preciated because angiotensin II does not penetrate the
blood–brain barrier (BBB). However, it has since been
shown that angiotensin II is produced in the brain, where
its production is regulated independently of the classical
renin-angiotensin system [27-29]. Hence, it is likely that
locally produced angiotensin II may have some par-
enchymal effects in the brain. For instance, angiotensin
II may be involved in the regulation of brain develop-
ment, neuronal migration, sensory information process-
ing, cognition, emotional responses, and cerebral blood
flow [28]. Consistent with this, studies have found that
angiotensin II receptors are expressed in neurons as
well as in endothelial cells [30,31].
Although the role of angiotensin II in the neuronal
death associated with acute brain injury has received little
research attention, several lines of evidence suggest that
the angiotensin system may be involved in acute neuronal
injury. For instance, ischemia-induced neuronal cell loss is
accompanied by the loss of angiotensin II receptors. In
addition, ACE inhibitors reduce oxidative neuronal death
in vitro as well as ischemic neuronal death in mice and
rats [32]. However, the precise mechanism underlying
angiotensin II-related neuroprotection is largely unknown.
Here, using mouse cortical cell cultures, we sought to
examine the possibility that the angiotensin system
modulates zinc-induced neuronal cell death. We found
that angiotensin II potentiates zinc-induced oxidative
neuronal death, probably via activation of the angiotensin
II type 2 receptor (AT2R) rather than AT1R. In addition,
we found that the induction and activation of NADPH
oxidase may underlie the oxidative stress-potentiating
effects of angiotensin II.
Results
Zinc exposure induces concentration-dependent cell
death in mixed cortical cultures containing neurons and
astrocytes [33]; with 15 min exposure, the 50% lethal
dose (LD50) of zinc was approximately 300 μM. To
analyze the modulating effect of angiotensin II on zinc
toxicity in cortical cell cultures, we exposed mixed cor-
tical cultures to 300 μM zinc for 15 min with or without
the addition of the indicated concentrations of angio-
tensin II. As expected, exposure to zinc alone induced
about 70% cell death compared to sham wash controls
(Figure 1A), whereas exposure to angiotensin II alone at
concentrations up to 50 μM for 18 h was not toxic to
cultured neurons or astrocytes. In contrast, addition of
angiotensin II (0.5–50 μM) significantly enhanced zinc-
induced cell death in a concentration-dependent manner
(Figure 1B). This potentiating effect was specific for zinc,
since addition of 1 μM angiotensin II did not alter the sub-
maximal calcium-overload excitotoxicity induced by 24-h
Figure 1 Angiotensin II potentiates zinc-induced neuronal cell death in cortical cell cultures. A) Phase-contrast (upper) and matching
propidium-iodide fluorescence photomicrographs (lower) of mixed cortical cell cultures after sham wash (CTL), 15 min treatment with 300 μM
zinc (Zn), or 15 min treatment with 300 μM zinc plus 1 μM angiotensin II (+Ang). Whereas zinc alone induced a moderate degree of cell death,
addition of angiotensin II significantly increased the toxicity, especially to neurons. B) LDH release (mean ± SEM, n = 9) in cortical cell cultures after
15 min exposure to 300 μM zinc or zinc plus angiotensin II (0.5–50 μM). Angiotensin II potentiated zinc-triggered cell death in a concentration-
dependent manner (*p < 0.05 versus zinc alone; two-tailed t-test). C) LDH release in cortical culture after a 24 h exposure to 60 μM glutamate,
20 μM NMDA, or 200 nM ionomycin in the absence or presence of 1 μM angiotensin II. Angiotensin II failed to potentiate calcium-overload
excitotoxicity.
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ionomycin (Figure 1C).
Since zinc can injure both neurons and astrocytes, we
examined whether the potentiation of zinc-induced
cortical cell death by angiotensin II exhibited specifi-
city toward neurons. Separate, near-pure neuronal cul-
tures and astrocytic cultures were prepared, and each
culture was exposed to zinc alone (300 μM) or together
with angiotensin II (0.5–50 μM). Zinc alone induced
about 50% cell death. Addition of angiotensin II signifi-
cantly potentiated zinc-induced cell death in near-pure
neuronal cultures in a concentration-dependent manner
(Figure 2A). In contrast, in astrocytic cultures, cell death
induced by zinc was not altered by the addition of the
same concentrations of angiotensin II (Figure 2B). Hence,
the effect of angiotensin II on zinc toxicity appears to be
selective for cultured neurons.Angiotensin II acts on two types of receptors: type 1
(AT1R) and type 2 (AT2R). To determine whether these
receptors are expressed in cultured cortical cells, we
performed Western blotting for both receptors in pure
neuronal, astrocytic, and mixed cortical cell cultures
(Figure 3A). In all cases, both AT1R and AT2R were de-
tected at mRNA and protein levels. We then used losar-
tan and PD123319, selective inhibitors of AT1R and
AT2R, respectively, to determine which of the two re-
ceptors mediated the potentiating effect of angiotensin
II. We first tested the effects of these inhibitors on the
neurotoxicity induced by zinc alone. Whereas losartan
showed no effect on neuronal death induced by 15 min
exposure to 300 μM zinc, PD123319 substantially reduced
the cell death (Figure 3B), indicating that activation of
AT2Rs contributes to zinc toxicity toward cultured cor-
tical cells. We next examined whether the potentiating
Figure 2 Potentiation of zinc toxicity by angiotensin II is specific to neurons. A) Bars denote LDH release (mean ± SEM, n = 7) in near-pure
neuronal cultures after 15 min exposure to 300 μM zinc or zinc plus 0.5, 1, or 50 μM angiotensin II (*p < 0.05, **p < 0.01 versus zinc alone;
two-tailed t-test). B) LDH release (mean ± SEM, n = 7) in astrocytic cultures after 15 min exposure to 300 μM zinc or zinc plus the indicated
concentrations of angiotensin II.
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by AT1R or AT2R. Again, PD123319, but not losartan,
blocked the toxicity-potentiating effect of angiotensin II
(Figure 3C), indicating a specific role for AT2Rs.
To further test the distinct role of AT2R in zinc
neurotoxicity, we used CGP42112, a specific agonist of
AT2R. Co-treatment of CGP42112 increased the neuro-
toxicity of zinc in a concentration-dependent manner in
cortical cell culture (Figure 3D). Similar to angiotensin
II, the potentiating effect of CGP42112 was evident in
near-pure neuronal culture (Figure 3E) and not in astro-
cytic culture (Figure 3F). Lastly, we also observed that
PD123319 blocked the potentiating effect of CGP42112,
while losartan showed no such effect (Figure 3G).
Although diverse intracellular events contribute to
zinc-triggered cell death [34], oxidative stress is con-
sidered a major mechanism [35]. Hence, it is plausible
that angiotensin II and AT2Rs specifically participate
in oxidative stress mechanisms in the context of zinc
neurotoxicity. To examine this possibility, we loaded
cortical neurons with H2-DCFDA, a fluorescent indica-
tor for superoxides, and examined ROS levels follow-
ing different treatment regimens. Exposure to 300 μM
zinc for 15 min substantially increased the levels of
ROS in cultured cortical neurons, an effect that was
markedly potentiated by the addition of 1 μM angio-
tensin II (Figure 4A). Co-incubation with the AT2R
inhibitor PD123319 (1 μM) blocked the zinc-induced
increases in ROS levels, whereas the AT1R inhibitor
losartan was not effective. Quantitative measurements
of H2-DCFDA fluorescence further confirmed that the
inhibition of AT2R specifically reduced ROS levels in
zinc-treated cells (Figure 4B). We also used N-acetyl-
L-cysteine (NAC) to suppress oxidative stress in zinc-
induced neuronal cell death, and found that suppression
of oxidative stress fully negated the potentiating effect of
angiotensin II (Figure 4C).Several studies have demonstrated that NADPH oxi-
dase is a key mediator of ROS generation in zinc
neurotoxicity [36]. This enzyme is expressed in neu-
rons and astrocytes in cortical cultures. Furthermore,
the levels of NADPH oxidase increase following zinc
exposure. Hence, we considered the possibility that
NADPH oxidase mediates the effect of angiotensin II,
first examining whether angiotensin II alters NADPH
oxidase activity in neurons treated with zinc. As we
previously reported, 15 min exposure of cortical cells
to 300 μM zinc increased the levels of the NADPH
subunit p67phox in both cytosolic and membrane
fractions, indicating that the total level of p67phox was
upregulated by zinc [36]. Notably, p67phox levels in-
creased to a greater degree in the membrane fraction
than in the cytosolic fraction, consistent with the
membrane translocation of p67phox, a characteristic
sign of NADPH oxidase activation. Addition of angio-
tensin II significantly increased the levels of p67phox in
both cytosolic and membrane fractions, whereas
addition of PD123319 blocked this effect (Figure 5A, B).
Angiotensin II alone and PD123319 alone induced no
changes in the level or distribution of p67phox. Hence,
angiotensin II potentiated zinc-triggered NADPH oxi-
dase induction as well as activation, likely through
AT2R activation. Further support for this possibility is
provided by the results of Rac activation assays, which
revealed similar changes. Specifically, whereas zinc in-
duced Rac activation, this activation was potentiated by
the addition of angiotensin II and blocked by the
addition of PD123319 (Figure 5C). We then tested the
causal relationship between the potentiating effect of
angiotensin II and NADPH activation by using apocy-
nin, a widely used inhibitor of NADPH oxidase. Indeed,
addition of 500 μM apocynin suppressed the potentiat-
ing effect of angiotensin II in zinc-induced neuronal cell
death (Figure 5D). Collectively, these results indicate
Figure 3 AT2R mediates zinc toxicity as well as the toxicity-potentiating effect of angiotensin II. A) Western blots for AT1R and AT2R in
astrocytic, mixed, and near-pure neuronal cultures showing that both neurons and astrocytes express substantial levels of both receptors. B) LDH
release (mean ± SEM, n = 6) in cortical cell cultures after 15 min exposure to 300 μM zinc alone or with addition of the selective AT1R inhibitor
losartan (500 nM) or selective AT2R inhibitor PD123319 (1 μM) (*p < 0.05 versus zinc alone; two-tailed t-test). C) LDH release (mean ± SEM, n = 5)
in cortical cell cultures after 15 min exposure to 300 μM zinc alone, zinc plus 1 μM angiotensin II, zinc plus angiotensin II and losartan, or zinc plus
angiotensin II and PD123319 (*p < 0.05 for differences between indicated values; two-tailed t-test). D) LDH release (mean ± SEM, n = 4) in cortical
cell cultures after 15 min exposure to 300 μM zinc or zinc plus CGP42112 (0.5 μM – 10 μM). CGP42112 potentiated zinc-triggered cell death in a
concentration-dependent manner (*p < 0.05 versus zinc alone; two-tailed t-test). E) LDH release (mean ± SEM, n = 9) in near-pure neuronal cultures
after 15 min exposure to 300 μM zinc or zinc plus 1 μM CGP42112 (*p < 0.05 versus zinc alone; two-tailed t-test). F) LDH release (mean ± SEM,
n = 6) in astrocytic cultures after 15 min exposure to 300 μM zinc or zinc plus the indicated concentrations of CGP42112. G) LDH release (mean ±
SEM, n = 10) in cortical cell cultures after 15 min exposure to 300 μM zinc alone, zinc plus 1 μM CGP42112, zinc plus CGP42112 and losartan, or
zinc plus CGP42112 and PD123319 (*p < 0.05 for differences between indicated values; two-tailed t-test).
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the mechanisms that contribute to the angiotensin II
potentiation of zinc-triggered oxidative stress in cortical
cultures.
Discussion
The central finding of the present study is that angio-
tensin II may modulate the oxidative injury triggered by
intracellular zinc dyshomeostasis in cultured cortical
neurons. Since the present cortical cell cultures containno endothelial cells or oligodendrocytes/microglial cells
[4,37], this angiotensin II effect is likely mediated by re-
ceptors on neurons and/or astrocytes. Our pharmaco-
logical data support the possibility that AT2R on neurons
is predominantly responsible for this effect.
Mouse cortical cell cultures have been used for more
than three decades to study the mechanisms of neuronal
death in the central nervous system [4,38]. This primary
culture contains mainly of neurons and supporting astro-
cytes. Compared with pure neuronal or astroglial cultures,
Figure 4 AT2R modulates the level of zinc-triggered oxidative stress in cortical cells. A) Cortical cells were loaded with H2-DCFDA (DCF) to
detect ROS as an indicator of oxidative stress, and subsequently treated with zinc (Zn), zinc plus angiotensin II (+Ang), zinc plus PD123319 (+PD),
or zinc plus losartan (+Losartan). Compared to sham-washed cultures, zinc treatment increased the level of DCF fluorescence in neurons, an effect
that was further augmented by addition of angiotensin II. PD123319 markedly attenuated the zinc-induced increase in DCF fluorescence in
neurons, whereas losartan had no effect. B) Bars denote relative DCF fluorescence in cortical cell cultures following 15 min exposure to zinc, zinc
plus angiotensin II, zinc plus PD123319, or zinc plus losartan (*p < 0.05 versus zinc alone; two-tailed t-test). C) LDH release (mean ± SEM, n = 4) in
cortical cell cultures after 15 min exposure to 300 μM zinc, zinc plus angiotensin II (1 μM), and zinc plus angiotensin II and NAC (1 mM). Addition
of NAC blocked the potentiating effect of angiotensin II in zinc-induced neuronal cell death (*p < 0.05, **p < 0.01 for differences between
indicated values; two-tailed t-test).
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brain, as neuron-astrocytic interactions remain intact.
Notably, the results presented here indicate that both neu-
rons and astrocytes express both AT1Rs and AT2Rs. In
theory, co-cultured astrocytes could influence neuronal
cell fate in this mixed culture. However, the fact that a
similar effect was obtained in near-pure neuronal cultures
favors the possibility that the effects of angiotensin II are
mediated by neuronal angiotensin II receptors.
A signaling role for angiotensin II in the brain was first
described decades ago. Previous studies have shown that
angiotensin II may be involved in hypothalamic signaling
processes, such as hormone regulation and sympathetic
control [28]. However, angiotensin II receptors are not
confined to the hypothalamus but are instead widely
expressed throughout the brain [39], suggesting that
angiotensin II may have broader roles in the brain. A
growing body of recent evidence suggests that the angio-
tensin system may directly modulate neuronal cell death
associated with acute brain injuries such as ischemia[40]. For instance, ACE inhibitors have been shown to
attenuate brain damage in a blood pressure-independent
manner [32]. In addition, angiotensin II receptor antago-
nists have been reported to reduce neuronal cell death in
acute brain injury [41], and to reduce apoptosis, inflamma-
tion, and oxidative stress in a rat hemorrhagic stroke
model [42]. Taken together, these results suggest that the
angiotensin system may have direct brain parenchymal ef-
fects. In addition, whereas BBB-impermeant ACE inhibi-
tors have little effect on Alzheimer’s disease symptoms,
BBB-permeant inhibitors such as perindopril significantly
delay the symptomatic progression in Alzheimer’s disease
patients [43]. Since the blood pressure-lowering effects
were identical in the two groups, this result strongly
supports an additional role of the angiotensin system in
the brain parenchyma.
Consistent with a role for angiotensin II in the brain
parenchyma, the present results indicate that angiotensin
II significantly potentiated zinc-triggered neuronal death
in cortical cell cultures. We examined zinc toxicity in the
Figure 5 AT2R modulates zinc-triggered NADPH oxidase activation in cortical cells. A) Western blotting for the cytosolic subunit of the
NADPH oxidase p67phox in cytosolic and membrane fractions of cortical cell cultures, sham-washed (CTL) or after 15 min exposure to 300 μM zinc,
zinc plus 1 μM angiotensin II, angiotensin II alone, zinc plus 1 μM PD123319, or PD123319 alone. B) Bars denote the relative density of p67phox
bands normalized to corresponding actin bands (mean ± SEM, n = 11) in the above Western blot experiments. Whereas angiotensin II or
PD123319 alone had no effect on the level or distribution of p67phox, zinc exposure substantially increased the levels of p67phox in both cytosolic
and membrane fractions, an effect that was significantly potentiated by addition of angiotensin II. Notably, p67phox increased to a greater degree
in the membrane fraction, indicating that zinc exposure not only induced, but also activated, NADPH oxidase. Addition of PD123319 inhibited
increases in p67phox in the membrane fraction induced by zinc plus angiotensin II (*p < 0.05, **p < 0.01 for differences between indicated values;
two-tailed t-test). C) Bars denote the level of Rac activation as assessed by G-LISA assay. Consistent with the pattern of NADPH oxidase subunit
translocation, zinc treatment increased Rac activity in cortical cells, an effect that was increased by angiotensin II and decreased by PD123319.
Again, neither angiotensin II nor PD123319 alone had any effect on the level of Rac activation (*p < 0.05, **p < 0.01 for differences between
indicated values; two-tailed t-test). D) LDH release (mean ± SEM, n = 4) in cortical cell cultures after 15 min exposure to 300 μM zinc, zinc plus
angiotensin II (1 μM), and zinc plus angiotensin II and apocynin (500 μM) (**p < 0.01 for differences between indicated values; two-tailed t-test).
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ports the possibility that zinc dyshomeostasis plays a key
role in neuronal death following acute brain injury. First,
zinc is present in large quantities in glutamatergic synaptic
boutons and is released with neuronal excitation or acute
insults such as ischemia [44]. Second, exposure of cultured
neurons to millimolar zinc causes neuronal death, mainly
via oxidative stress and partially through caspase-mediated
apoptosis [35]. Third, following acute brain injuries such
as ischemia, seizure or trauma, degenerating neurons ex-
hibit novel zinc accumulation in their cell bodies [45].
Finally, inhibition of zinc accumulation with zinc chelators
markedly reduces neuronal cell death in the above condi-
tions [46]. Hence, neuronal death induced by zinc seems areasonable in vitro model for the neuronal death associ-
ated with acute brain injury.
Further supporting the role of the angiotensin system
in zinc-triggered neuronal death, PD123319, a selective
inhibitor of the AT2R, significantly attenuated zinc tox-
icity in cortical cell culture. In contrast, losartan, a se-
lective inhibitor of AT1Rs, showed no protective effect.
Since little information about the angiotensin receptor
signaling cascade in brain cells is available, it is unclear
how AT2R selectively affects zinc neurotoxicity. In any
event, PD123319 blocked the increase in ROS levels in
zinc-treated cortical neurons, indicating that AT2R
modulates oxidative stress in brain cells under condi-
tions of zinc dyshomeostasis. Again, the fact that similar
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but not in pure astrocyte cultures, supports the possibility
that AT2Rs on neurons likely mediate the effects of angio-
tensin II reported here. This protective effect exerted by
AT2Rs appears to be in conflict with studies reporting a
protective effect of an AT2R agonist, CGP42112, in the
brain [47]; this difference suggests additional complexities
regarding the role of AT2R in brain injury, including the
possibility that AT2R may play different roles depending
on the mode of cell death.
Several studies have demonstrated that zinc neuro-
toxicity is mainly caused by oxidative stress [35,48]. Al-
though diverse signaling molecules, such as protein
kinase C (PKC) and ERK (extracellular signal-regulated
kinase) appear to be important in upstream events, the
activation and induction of a superoxide-generating
NADPH oxidase is among the main effector mecha-
nisms that directly trigger oxidative neuronal death
[36]. NADPH oxidase is mainly expressed in phagocytes;
however, recent evidence indicates that this enzyme is
expressed more broadly in many types of cells. For in-
stance, in the peripheral nervous system, sympathetic
ganglion neurons express NADPH oxidase. In the cen-
tral nervous system, both neurons and astrocytes, in
addition to phagocytic microglial cells, express NADPH
oxidase [49]. Interestingly, we found that zinc toxicity,
but not calcium-overload glutamate toxicity, selectively
activated and induced NADPH oxidase in cortical cell
cultures [36]. Consistent with this, angiotensin II also
selectively potentiated zinc toxicity through activation
of NADPH oxidase; again, calcium-overload excitotoxicity
was not altered by angiotensin II. Consistently, we also
found that NAC and apocynin inhibited the potentiating
effect of angiotensin II, thus further supporting the idea
that angiotensin II exerts its death-potentiating effect
through activation of NADPH oxidase and ROS pro-
duction. In this context, it is intriguing that angiotensin
II augmented the zinc-induced increase in NADPH oxi-
dase subunit in cortical cell cultures by acting through
AT2R (reversed by addition of PD123319). Although
deconvoluting the entire signaling cascade from AT2R
activation to NADPH oxidase activation/induction is
beyond the scope of this study, it is likely that PKC
activation is involved [50].Conclusions
The present study demonstrates a role for the angiotensin
system in zinc-triggered neuronal cell death. Since zinc
toxicity is likely a key component in neuronal death asso-
ciated with acute brain injury in diverse animal models,
the use of BBB-permeable ACE inhibitors or angiotensin
II receptor antagonists may provide neuroprotection in
some cases of acute brain injury.Methods
Cortical cell cultures
Mixed cortical cell cultures containing both neurons and
astrocytes were prepared from fetal mice at day 15 of
gestation. Briefly, dissociated cortical cells were plated
onto a previously established astroglial cell monolayer at
5 hemispheres per plate (Nunc, Roskilde, Denmark) in
plating medium (Dulbecco’s modified Eagle medium;
Gibco BRL, Rockville, MD, USA) supplemented with
20 mM glucose, 38 mM sodium bicarbonate, 2 mM glu-
tamine, 5% fetal bovine serum, and 5% horse serum.
Cytosine arabinoside (10 μM) was added 5–6 d after
plating to halt the growth of non-neuronal cells.
Astroglial cultures were prepared from neocortices of
newborn mice (postnatal day 1–3) and plated at 2 hemi-
spheres per plate in the same plating medium indicated
above but supplemented with 7% fetal bovine serum and
7% horse serum. Glial cultures were used for neuronal
plating between days in vitro (DIV) 14 and 28, when
they had formed a confluent monolayer.LDH release assay
Overall neuronal cell injury in mixed cortical cultures
was quantitatively assessed by measuring lactate de-
hydrogenase (LDH; EC 1.1.1.27) activity released from
damaged cells into the culture medium [51]. Each LDH
value was scaled to the mean value in sister positive con-
trol cultures treated with 300 μM glutamate for 24 h
(defined as 100%) after subtracting the mean back-
ground value in sister control untreated cultures that
underwent sham wash only (defined as 0%). The positive
control (300 μM glutamate) induced near-complete
neuronal death without producing glial damage.Measurement of intracellular ROS levels by DCF
fluorescence microscopy
Levels of intracellular free radicals were measured using
the peroxide-sensitive fluorescent probe, 5-(and-6)-carboxy-
2′,7′-dichlorohydrofluorescein diacetate (H2-DCFDA), as
described by the manufacturer (Molecular Probes, Eugene,
OR, USA). Briefly, cells were incubated for 10 min in the
presence of 5 μM H2-DCFDA (DCF), washed with minimal
essential medium (MEM), and viewed and photographed
under a fluorescence microscope.Measurement of Rac activity
Rac activation was measured using the G-LISA Rac activa-
tion assay Biochem Kit (Cytoskeleton Inc. CO, USA) as
described by the manufacturer. Briefly, cell lysates were
incubated in a Rac-GTP affinity plate for 30 min, and
active Rac was detected with a Rac-specific antibody.
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NADPH oxidase component p67phox
Membrane translocation of the NADPH oxidase compo-
nent p67phox was detected by Western blot analysis of
membrane/cytosol-fractionated cell lysates. Cells were
lysed and collected using hypotonic lysis buffer (1 mM
NaHCO3 and 5 mM MgCl2 in RIPA buffer), sonicated
briefly, and centrifuged at 600 × g for 10 min at 4°C.
The membrane fraction was separated from the cytosol
fraction by centrifuging the supernatant at 55,000 rpm
for 1.5 h in an Optima TLX ultracentrifuge (Beckman
Coulter, CA, USA). After centrifugation, the resulting
supernatant (cytosol fraction) was transferred to a separ-
ate tube. The pellet (membrane fraction) was incubated
on ice in RIPA buffer for 30 min, and then sonicated
and centrifuged at 12,000 rpm for 5 min in at 4°C. The
supernatant of this final centrifugation step was col-
lected as the membrane fraction. p67phox was detected
and quantified in both cytosol and membrane fractions
by Western blotting.
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